Clinical, epidemiological and laboratory research in myeloma and related disorders. Several clinical trials have been conducted on the treatment of myeloma, including two pivotal trials that led to regulatory approval of thalidomide for treatment of the disease in the United States and Europe. Dr. Rajkumar's laboratory interests are in the areas of angiogenesis and development of new agents for the treatment of myeloma.
Tags: health disparities, Mayo Clinic, Minnesota project, myeloma, project, Projects, S. Vincent Rajkumar M.D.